Our Expertise & Rationale

Patient-based disease models carry a huge potential for phenotypic drug discovery and the generation of more efficient drugs and next generation medicine. Our programs are divided into two development steps.    

First, we design most authentic disease models by differentiating patient-derived induced pluripotent stem cells into disease relevant cell types. After phenotypic and functional validation, they are transformed into valuable, fully automated assays.

In a second step, we combine our assays to be screened with large compound libraries for the identification and development of valuable first-in-class lead compounds.